How to Check Curis Lifesciences IPO Allotment Status

Curis Lifesciences Limited is a pharmaceutical company engaged in developing, manufacturing, and distributing a wide range of pharmaceutical products. The company serves over 100 corporate clients globally and domestically on a loan license or contract manufacturing basis, with additional brand marketing operations in Yemen and Kenya.

As of March 31, 2025, Curis Lifesciences reported total assets of ₹42.53 crore and a net profit of ₹6.11 crore. The company operates a state-of-the-art manufacturing facility in Sanand, Gujarat, supported by a scalable business model and a strong quality assurance framework.

The Curis Lifesciences IPO had a total issue size of ₹27.52 crore, comprising entirely a fresh issue of ₹27.52 crore. The IPO opened on November 7, 2025, and closed on November 11, 2025. The allotment is expected to be finalized on Wednesday, November 12, 2025. The price band was set at ₹120 to ₹128 per share.

Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!

Open Account Now

Steps to Check Curis Lifesciences IPO Allotment Status on Registrar Site

• Visit the MUFG Intime India Pvt. Ltd. 
• Select "Curis Lifesciences" from the dropdown menu on the allotment status page
• Enter your PAN ID, Demat Account Number, or Application Number in the designated field
• Complete the captcha verification process and click on the "Submit" button to view your allotment status

Steps to Check Curis Lifesciences IPO Allotment Status on BSE

• Navigate to the BSE IPO Allotment Status Page
• Select the issue type: equity/debt
• Choose "Curis Lifesciences" from the list of active IPOs in the dropdown menu
• Input your Application Number and PAN ID in the required fields
• Verify the captcha and click "Search" to check your allotment status

Curis Lifesciences IPO Subscription Status

Curis Lifesciences IPO received strong investor participation, being subscribed 74.39 times overall. Below is the category-wise subscription status as of 6:19:59 PM on November 11, 2025:

• QIB Category (Ex Anchor): 96.17 times
• Non-Institutional Investors (NII): 115.46 times
• Individual Investors: 44.28 times
   

Curis Lifesciences IPO Share Price and Investment Details

The minimum investment required was ₹2,56,000 for 2 lots (2,000 shares). The issue raised ₹7.80 crore from anchor investors. Given the strong subscription levels with QIB participation at 96.17 times, NII at 115.46 times, and retail at 44.28 times, listing expectations remain positive.

Utilisation of IPO Proceeds

The proceeds from the IPO will be utilized for:

• Capital expenditure for upgrading and improving existing manufacturing facilities – ₹2.44 crore
• Construction of a new storage facility – ₹3.62 crore
• Prepayment or repayment of secured loans – ₹1.86 crore
• Product registration in other countries – ₹2.69 crore
• Working capital requirements – ₹11.25 crore
• General corporate purposes
   

Business Overview

Curis Lifesciences Limited manufactures and markets pharmaceutical formulations across tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments. Its clients include leading pharmaceutical companies globally and domestically. The company’s key strengths include an experienced management team, strategic manufacturing location, wide product portfolio, and scalable business model.

However, the company operates in a highly competitive and fragmented pharmaceutical segment. The post-issue P/E ratio stands at 12.01, and the Price-to-Book Value is 12.64, indicating fair pricing for medium-term investors.